| Bioactivity | Cyslabdan ((+)-Cyslabdan) is a novel compound with the potential to enhance the activity of imipenem against methicillin-resistant Staphylococcus aureus. Cyslabdan exerts its antibacterial effect by inhibiting the synthesis of pentapeptide cross-links[1]. |
| CAS | 956507-17-8 |
| Formula | C25H41NO5S |
| Molar Mass | 467.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation |
Cyslabdan
CAS: 956507-17-8 F: C25H41NO5S W: 467.66
Cyslabdan ((+)-Cyslabdan) is a novel compound with the potential to enhance the activity of imipenem against methicillin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.